Efficacy and long-term outcomes of palivizumab prophylaxis to prevent respiratory syncytial virus infection in infants with cystic fibrosis in Northern Ireland. (Q40818801)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 January 2016

Language	Label	Description	Also known as
English	Efficacy and long-term outcomes of palivizumab prophylaxis to prevent respiratory syncytial virus infection in infants with cystic fibrosis in Northern Ireland.	scientific article published on 25 January 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26808981 AND SRC:MED&resulttype=core&format=json

6 March 2020

Efficacy and long-term outcomes of palivizumab prophylaxis to prevent respiratory syncytial virus infection in infants with cystic fibrosis in Northern Ireland (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26808981 AND SRC:MED&resulttype=core&format=json

6 March 2020

cystic fibrosis

0 references

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26808981 AND SRC:MED&resulttype=core&format=json

6 March 2020

author name string

H E Groves

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26808981 AND SRC:MED&resulttype=core&format=json

6 March 2020

L Jenkins

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26808981 AND SRC:MED&resulttype=core&format=json

6 March 2020

M Macfarlane

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26808981 AND SRC:MED&resulttype=core&format=json

6 March 2020

A Reid

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26808981 AND SRC:MED&resulttype=core&format=json

6 March 2020

M D Shields

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26808981 AND SRC:MED&resulttype=core&format=json

6 March 2020

publication date

25 January 2016

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26808981 AND SRC:MED&resulttype=core&format=json

6 March 2020

Pediatric Pulmonology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26808981 AND SRC:MED&resulttype=core&format=json

6 March 2020

51

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26808981 AND SRC:MED&resulttype=core&format=json

6 March 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26808981 AND SRC:MED&resulttype=core&format=json

6 March 2020

379-385

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26808981 AND SRC:MED&resulttype=core&format=json

6 March 2020

Contribution of RSV to bronchiolitis and pneumonia-associated hospitalizations in English children, April 1995-March 1998.

1 reference

https://api.crossref.org/works/10.1002/PPUL.23376

21 January 2018

Driscoll Children's Hospital respiratory syncytial virus database: risk factors, treatment and hospital course in 3308 infants and young children, 1991 to 2002.

1 reference

https://api.crossref.org/works/10.1002/PPUL.23376

21 January 2018

Health care utilisation of prematurely born, preschool children related to hospitalisation for RSV infection

1 reference

https://api.crossref.org/works/10.1002/PPUL.23376

21 January 2018

Lower respiratory tract infections among human immunodeficiency virus-exposed, uninfected infants

1 reference

https://api.crossref.org/works/10.1002/PPUL.23376

21 January 2018

Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1002/PPUL.23376

21 January 2018

Effects of upper respiratory tract infections in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002/PPUL.23376

21 January 2018

Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma--possible synergism with Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1002/PPUL.23376

21 January 2018

Infection with respiratory syncytial virus enhances expression of native receptors for non-pilate Neisseria meningitidis on HEp-2 cells

1 reference

https://api.crossref.org/works/10.1002/PPUL.23376

21 January 2018

Use of Palivizumab for prevention of hospitalization as a result of respiratory syncytial virus in infants with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002/PPUL.23376

21 January 2018

Prophylaxis against respiratory syncytial virus in young children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002/PPUL.23376

21 January 2018

Cochrane Database of Systematic Reviews

1 reference

https://api.crossref.org/works/10.1002/PPUL.23376

21 January 2018

Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease

1 reference

https://api.crossref.org/works/10.1002/PPUL.23376

21 January 2018

A survey of palivizumab for infants with cystic fibrosis in the UK.

1 reference

https://api.crossref.org/works/10.1002/PPUL.23376

21 January 2018

Is palivizumab effective as a prophylaxis of respiratory syncytial virus infections in cystic fibrosis patients? A meta-analysis

1 reference

https://api.crossref.org/works/10.1002/PPUL.23376

21 January 2018

Anti-RSV prophylaxis efficacy for infants and young children with cystic fibrosis in Ireland

1 reference

https://api.crossref.org/works/10.1002/PPUL.23376

21 January 2018

Increased rate of lung function decline in Australian adolescents with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002/PPUL.23376

21 January 2018

Severe viral respiratory infections in infants with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002/PPUL.23376

21 January 2018

Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002/PPUL.23376

21 January 2018

Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort

1 reference

https://api.crossref.org/works/10.1002/PPUL.23376

21 January 2018

Hospitalisation for RSV infection in ex-preterm infants-implications for use of RSV immune globulin

1 reference

https://api.crossref.org/works/10.1002/PPUL.23376

21 January 2018

Impact of palivizumab on expected costs of respiratory syncytial virus infection in preterm infants: potential for savings

1 reference

https://api.crossref.org/works/10.1002/PPUL.23376

21 January 2018

Identifiers

10.1002/PPUL.23376

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26808981 AND SRC:MED&resulttype=core&format=json

6 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26808981 AND SRC:MED&resulttype=core&format=json

6 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40818801&oldid=1507823172"